68.49 (0.56%)
As of Oct 04, 2022
Source:
We are a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, our goal is to transform the treatment and care of sickle cell disease, or SCD, a lifelong, devastating inherited blood disorder that is marked by red blood cell, or RBC, destruction and occluded blood flow and hypoxia, which leads to anemia, stroke, multi-organ failure, severe pain crises, and shortened patient life span.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | 650741-7700 |
Industry | manufacturing |
CEO | Ted W. Love, M.D. |
Website | gbtsource.com |